Disclosed herein are new antiviral compounds, together with pharmaceutical compositions that include one or more antiviral compounds, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a paramyxovirus viral infection with one or more small molecule compounds. Examples of paramyxovirus infection include an infection caused by human respiratory syncytial virus (RSV).
promoted zirconiasolidacid in particular has been the target catalysts among various solidacids described in earlier reports due to their established advantages. Sulphate freezirconia basedsolidacids such as MoOx/ZrO2, VOx/ZrO2 and WOx/ZrO2 have been synthesized and used as solidacid catalysts in a little liquid and vapour phase reactions. Although this sulphate free-zirconia is superior solid acid